CorMedix (CRMD)
(Delayed Data from NSDQ)
$5.41 USD
-0.30 (-5.17%)
Updated May 9, 2024 04:00 PM ET
After-Market: $5.42 +0.01 (0.18%) 6:14 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO5/9/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | -23.81% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.82 |
Next Year | -0.32 |
EPS (TTM) | -0.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 0.75M | 14.60M | 66.95M |
# of Estimates | NA | 1 | 1 | 1 |
High Estimate | NA | 0.75M | 14.60M | 66.95M |
Low Estimate | NA | 0.75M | 14.60M | 66.95M |
Year ago Sales | 0.00M | 0.00M | 0.07M | 14.60M |
Year over Year Growth Est. | NA | NA | 22,024.56% | 358.56% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.27 | -0.82 | -0.32 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.27 | -0.27 | -0.82 | -0.32 |
Low Estimate | -0.27 | -0.27 | -0.82 | -0.32 |
Year ago EPS | -0.24 | -0.25 | -0.91 | -0.82 |
Year over Year Growth Est. | -12.50% | -8.00% | 9.89% | 60.98% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.27 | -0.82 | -0.32 |
7 Days Ago | -0.27 | -0.27 | -0.82 | -0.32 |
30 Days Ago | -0.27 | -0.27 | -0.83 | -0.31 |
60 Days Ago | -0.26 | -0.28 | -0.96 | NA |
90 Days Ago | -0.26 | -0.28 | -0.98 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.27 | -0.82 | -0.32 |
Zacks Consensus Estimate | -0.27 | -0.27 | -0.82 | -0.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.17 | -0.25 | -0.24 | NA |
Estimate | -0.21 | -0.21 | -0.22 | -0.20 | NA |
Difference | -0.05 | 0.04 | -0.03 | -0.04 | -0.02 |
Surprise | -23.81% | 19.05% | -13.64% | -20.00% | -9.60% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more